Brevan Howard Capital Management LP Invests $420,000 in Integer Holdings Co. (NYSE:ITGR)

Brevan Howard Capital Management LP acquired a new stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 3,166 shares of the medical equipment provider's stock, valued at approximately $420,000.

Other hedge funds have also made changes to their positions in the company. Mather Group LLC. grew its position in Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 143 shares in the last quarter. Lee Danner & Bass Inc. acquired a new stake in shares of Integer during the 4th quarter valued at $27,000. R Squared Ltd acquired a new stake in shares of Integer in the 4th quarter valued at $44,000. Sterling Capital Management LLC lifted its stake in shares of Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after purchasing an additional 279 shares during the last quarter. Finally, Principal Securities Inc. raised its holdings in Integer by 31.2% in the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock worth $85,000 after acquiring an additional 152 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Trading Down 1.1%

ITGR traded down $1.38 during mid-day trading on Wednesday, hitting $119.62. The stock had a trading volume of 544,515 shares, compared to its average volume of 367,823. The stock's fifty day simple moving average is $118.36 and its 200-day simple moving average is $129.67. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a market capitalization of $4.17 billion, a price-to-earnings ratio of 35.60, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. Integer Holdings Co. has a 1-year low of $104.93 and a 1-year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The company had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same quarter in the prior year, the firm earned $1.14 earnings per share. The firm's revenue was up 7.3% compared to the same quarter last year. As a group, research analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ITGR. StockNews.com downgraded shares of Integer from a "hold" rating to a "sell" rating in a report on Friday, April 25th. Truist Financial set a $150.00 target price on shares of Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Benchmark reduced their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Oppenheimer lowered shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Finally, KeyCorp reduced their target price on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $145.56.

Insider Activity

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer now owns 47,000 shares of the company's stock, valued at $5,788,990. This trade represents a 87.82% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 2.16% of the company's stock.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.